Olive Diagnostics, an Israeli medtech startup, offers KG, the world’s first artificial intelligence (AI)-based optical device capable of early detection of diseases at home or in the clinic. The company extended its seed round of investment, now bringing in a total of $7.3 million after raising an additional $1.5 million.
Think of it this way: It is time-consuming and not always convenient to travel to a lab to give urine and stool samples. And for the elderly and the infirm, this is not always practical, or possible. Now, think about that dreaded walk from the bathroom to the nurses’ station holding that little cup in your hand with whatever is inside it. Gross and embarrassing – right?
So, now there is a way to avoid all of that. Someday soon you will be able to provide such samples in the privacy of your own home and the device will do the testing and send the results back to the doctor for you. Also, soon enough this kind of tech will work for any and all medical issues. If you hate going to the doctor, you won’t have to anymore. You will be able to step into a Star Trek like device which will scan your whole body and provide instant results.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at firstname.lastname@example.org.
Remember the Covid shutdowns when people were afraid to leave their homes, especially to see the doctor and have to mingle among sick people? Well, if this tech already existed three years ago that would not have been necessary.
And there is another even more important advantage to such technology. Early detection is vital to the treatment of all diseases, especially cancer and diseases of vital organs. If you notice any bad symptoms you just test yourself immediately without even needing to see a doctor.
Founded in 2019 by Guy Goldman (CEO) and Corey Katz, Olive Diagnostics’ equipment, which attaches to any toilet, accurately detects biomarkers for a variety of common medical ailments and diseases, including some types of prostate, ovarian, and kidney malignancies; heart failure; dehydration; kidney stones; and inflammation of the urine bladder.
KG will send medical information to family members and caregivers in order to detect the risk of dehydration and provide insight into people’s bowel movements. The KG device is an essential tool for the elderly, where early detection can significantly improve both quality of life and care.
“The milestone of receiving the CE Marking provides validation for our vision and technology and paves the way for us to enter the European market,” said Guy Goldman, CEO of Olive Diagnostics. “Olive KG is already installed at several assisted living facilities in Holland, and we believe that our device will transform medical care to one of non-invasive prevention, aiding patients and healthcare providers to detect diseases earlier, even before symptoms appear.”